×
About 1,305 results

ALLMedicine™ Mean Corpuscular Volume Center

Research & Reviews  461 results

Cyanosis, hemolysis, decreased HbA1c and abnormal co-oximetry in a patient with hemoglo...
https://doi.org/10.1080/16078454.2021.1999048
Hematology (Amsterdam, Netherlands); Göttgens EL, Baks K et. al.

Nov 19th, 2021 - We describe a first Dutch case of Hb M Saskatoon (HBB:c.190C > T p.His64Tyr) in a 47-year-old female Dutch patient who presented with cyanosis, hemolysis, and abnormal co-oximetry. A mean corpuscular volume (MCV) of 105 fL caused by reticulocytosi...

A randomised controlled provider-blinded trial of community health workers in sickle ce...
https://doi.org/10.1111/bjh.17952
British Journal of Haematology; Smith WR, McClish DK et. al.

Nov 18th, 2021 - Hydroxyurea (hydroxycarbamide) (HU) for sickle cell anaemia (SCA) is underutilised. Case management is an evidence-based health management strategy and in this regard patient navigators (PNs) may provide case management for SCA. We hypothesised th...

Mean corpuscular volume, hematocrit and polycythemia.
https://doi.org/10.1080/16078454.2021.1994173
Hematology (Amsterdam, Netherlands); Yavorkovsky LL

Nov 11th, 2021 - Mean corpuscular volume (MCV) as a measure of the size of red blood cells (RBCs) has been pivotal in the diagnosis and morphologic classification of anemias for over a century. Despite its ubiquitous use and time-honored diagnostic value, one esse...

Molecular analysis of alpha- and beta-thalassemia in Meizhou region and comparison of g...
https://doi.org/10.1002/jcla.24105
Journal of Clinical Laboratory Analysis; Wu H, Huang Q et. al.

Nov 10th, 2021 - Thalassemia is a group of inherited autosomal recessive hemolytic anemia disease caused by reduced or absent synthesis of globin chain/chains of hemoglobin. Only few studies showed the molecular characterization of α- and β-thalassemia in Meizhou ...

Treatment of Hemochromatosis
https://clinicaltrials.gov/ct2/show/NCT00007150

Oct 19th, 2021 - Hereditary hemochromatosis (HH) occurs in 1 in every 200-250 individuals of northern European descent, and is the most common inherited disease in this population. Although the molecular pathophysiology remains incompletely understood, a homozygou...

see more →

Clinicaltrials.gov  10 results

Treatment of Hemochromatosis
https://clinicaltrials.gov/ct2/show/NCT00007150

Oct 19th, 2021 - Hereditary hemochromatosis (HH) occurs in 1 in every 200-250 individuals of northern European descent, and is the most common inherited disease in this population. Although the molecular pathophysiology remains incompletely understood, a homozygou...

Haemoglobin Concentration on COVID-19
https://clinicaltrials.gov/ct2/show/NCT04377607

Sep 16th, 2020 - In late December 2019, cases of pneumonia of unknown etiology began to appear in Wuhan, Hubei, China. This disease, which was named COVID-19 by the World Health Organization (WHO) on February 11, 2020, was identified as serious acute respiratory s...

Determinants of Neonatal Anemia in Women Carrying Multiples
https://clinicaltrials.gov/ct2/show/NCT01582802

Feb 7th, 2020 - Pregnant women (n=100-125) carrying multiples (twins and triplets) will be identified when entering prenatal care. Women will be invited to participate in a longitudinal study of Fe homeostasis across pregnancy and at delivery in the maternal / ne...

Iron Parameters in Non-anemic First Trimester Gravidas
https://clinicaltrials.gov/ct2/show/NCT03670537

Jun 26th, 2019 - The 2015 United States Preventive Services Task Force (USPSTF) stated "there is insufficient evidence to recommend the routine screening for iron deficiency in non-anemic gravidas". The basis for this recommendation is the lack maternal or fetal o...

Vitamin B12 Pregnancy Supplementation
https://clinicaltrials.gov/ct2/show/NCT03522428

May 11th, 2018 - Pregnancy is associated with increased requirements for iron and increased blood volume of up to 40%. Because expansion in plasma volume is higher than the increase in the mass of red blood cells, there is a fall in hemoglobin concentration, which...

see more →

News  51 results

Diverse Set of Biomarkers Tied to Increased MDD Incidence
https://www.medscape.com/viewarticle/954678

Jul 13th, 2021 - Takeaway In a large community-based cohort study, biological markers of liver, kidney and endocrine dysfunction, innate immunity, anaemia and macrocytosis were associated with an increased 5-year incidence of major depressive disorder (MDD). Why t...

FDA Grants Breakthrough Therapy Designation to Rusfertide for Polycythemia Vera
https://www.onclive.com/view/fda-grants-breakthrough-therapy-designation-to-rusfertide-for-polycythemia-vera

Jun 4th, 2021 - The FDA has granted breakthrough therapy designation to rusfertide (PTG-300) as a potential therapeutic option for patients with polycythemia vera to reduce erythrocytosis in those who do not require further treatment for thrombocytosis and/or leu...

Olaparib Improves PFS as Frontline Maintenance in Ovarian Cancer
https://www.onclive.com/view/olaparib-improves-pfs-as-frontline-maintenance-in-ovarian-cancer

Dec 4th, 2020 - Sean Bohen, MD, PhD Olaparib (Lynparza) tablets reduced the risk of disease progression or death compared with placebo as frontline maintenance therapy for women with BRCA-positive advanced ovarian cancer, according to findings from the randomize...

AstraZeneca: Pioneers in Ovarian Cancer
https://www.onclive.com/view/astrazeneca-pioneers-in-ovarian-cancer

Nov 13th, 2020 - Over two years ago, women diagnosed with germline BRCA-mutated advanced ovarian cancer had limited treatment options, including chemotherapy or investigational treatments through clinical trials. In late 2014, AstraZeneca was proud to introduce a...

Fast Five Quiz: Alcohol Use Disorder
https://reference.medscape.com/viewarticle/936600_5

Sep 2nd, 2020 - Alcohol biomarkers are physiologic indicators of alcohol exposure or ingestion and may reflect the presence of an alcohol use disorder. These biomarkers are not meant to be a substitute for a comprehensive history and physical examination by an ap...

see more →